Related Experiment Video
Updated: Jun 5, 2026
04:05
Endoscopic Vacuum Therapy for the Treatment of Anastomotic Leakage after Total Gastrectomy with Esophagojejunostomy
Published on: August 22, 2025
[Octreotide acetate for persistent cylothorax after descending aorta replacement]
Hirokuni Naganuma1, Koji Kawahito, Yoko Matsumura
1Hirokuni Naganuma, Department of Cardiovascular Surgery, Jikei University, Tokyo, Japan.
Kyobu Geka. the Japanese Journal of Thoracic Surgery
|December 24, 2010
Summary
Octreotide acetate effectively treated persistent chylothorax after thoracic aorta replacement surgery. This treatment reduced pleural fluid drainage when conventional methods failed, offering a new therapeutic option for this serious complication.
Area of Science:
- Cardiovascular Surgery
- Thoracic Surgery
- Medical Complications
Background:
- Chylothorax is a serious complication following thoracic aorta replacement.
- Persistent chylothorax can occur despite conventional medical treatments.
- Aortic dissection requiring surgical repair presents significant risks.
Observation:
- A 59-year-old female developed massive chylothoracic pleural fluid post-descending aorta replacement.
- Conventional medical treatments were ineffective in managing the persistent chylothorax.
- Computed tomography confirmed acute dissection in the descending aorta.
Findings:
- Octreotide acetate administration led to a significant decrease in chylothoracic pleural fluid drainage.
- The patient's persistent chylothorax showed improvement with octreotide acetate.
- The exact mechanism of octreotide acetate's effectiveness is not fully understood.
Implications:
- Octreotide acetate shows promise as an effective treatment for persistent chylothorax post-thoracic aorta surgery.
- This finding may lead to improved patient outcomes and reduced morbidity.
- Further research into the mechanism of action is warranted to optimize its use.